Improving vaccine uptake: an overview

Michelle Anne Falconer1

  • 1Immunisation Co-ordinator; St Helens; Merseyside, UK.

Insights

This study enhanced childhood immunization services by offering catch-up vaccination sessions, increasing vaccine uptake by 39%. These accessible sessions improved vaccination rates for MMR and other crucial childhood vaccines.

Area of Science:

  • Public Health
  • Pediatrics
  • Immunization Services

Background:

  • Children aged 12 months to 5 years often have incomplete immunization status.
  • There is a need to improve access to and uptake of essential childhood vaccines.

Purpose of the Study:

  • To improve the quality of vaccination services by offering timely appointments.
  • To increase immunization coverage in young children through catch-up sessions.

Main Methods:

  • A pilot catch-up immunization session was conducted for under-immunized children aged 12 months to 5 years.
  • Following the pilot, four additional sessions were delivered in alternative venues.
  • Attendance rates and vaccine administration data were collected.

Main Results:

  • A total of 398 children attended the four sessions, with a 39% improvement in attendance.
  • 728 vaccines were administered, including MMR, Pre-school boosters, Hib/MenC, and PCV.
  • MMR vaccine uptake at 24 months increased by 9%; first-dose MMR uptake in five-year-olds rose from 91.9% to 94%.

Conclusions:

  • Implementing new delivery methods for immunization sessions can enhance access.
  • Utilizing alternative venues and offering catch-up sessions successfully increases vaccine uptake.
  • Improved immunization coverage is achievable through proactive service delivery strategies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...